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Cutting Edge: Regulation of Exosome Secretion by the
Integral MAL Protein in T Cells
Leandro N. Ventimiglia,* Laura Ferna´ndez-Martı´n,* Emma Martı´nez-Alonso,†
Olga M. Anto´n,* Milagros Guerra,‡ Jose´ Angel Martı´nez-Mena´rguez,†
Germa´n Andre´s,‡ and Miguel A. Alonso*
Exosomes secreted by T cells play an important role in
coordinating the immune response. HIV-1 Nef hijacks
the route of exosome secretion of T cells to modulate
the functioning of uninfected cells. Despite the impor-
tance of the process, the protein machinery involved
in exosome biogenesis is yet to be identified. In this
study, we show that MAL, a tetraspanning membrane
protein expressed in human T cells, is present in endo-
somes that travel toward the plasma membrane for exo-
some secretion. In the absence of MAL, the release of
exosome particles and markers was greatly impaired.
This effect was accompanied by protein sorting defects
at multivesicular endosomes that divert the exosomal
marker CD63 to autophagic vacuoles. Exosome release
induced by HIV-1 Nef was also dependent on MAL ex-
pression. Therefore, MAL is a critical element of the ma-
chinery for exosome secretion andmay constitute a target
for modulating exosome secretion by human T cells.
The Journal of Immunology, 2015, 195: 810–814.
T
he term exosome applies to membranous vesicles of
endosomal origin with a diameter of 40–100 nm that
are released into the extracellular space. Exosomes are
currently considered to be vehicles that transfer biomolecules
to recipient cells to modulate their activity (1). HIV-1 usurps
the exosome-based intercellular communication network of
T cells to render quiescent T cells permissive to HIV-1 rep-
lication (2, 3). Exosomes from regulatory T cells can suppress
effector T cells by delivering microRNAs via exosomes (4).
These findings suggest that modulation of the exosome route
in T cells may be of therapeutic value for preventing T cell–
mediated diseases such as inflammation or for interfering with
the progression of HIV-1 infection (5, 6).
Exosomes are generated as intraluminal vesicles (ILV) in
multivesicular endosomes (MVE). Additionally, MVE contain
ILV that are to be delivered to lysosomes (7). The endosomal
sorting complex responsible for transport (ESCRT) is re-
sponsible for ILV formation and cargo sorting in the endo-
lysosome route (8) and for exosome secretion in some (9), but
not in all (10), cell types. Release of the exosomal marker
CD63 in Jurkat T cells is dependent on ceramide but inde-
pendent of Hrs (11), which is a component of the ESCRT
machinery. Despite the interest from a fundamental point of
view and in the applications that might stem from it, the
identity of the components of the protein machinery under-
lying the process of exosome secretion in T cells remains
a mystery.
MAL is a 17-kDa tetraspanning membrane protein known
to be essential for specialized routes of protein transport to the
plasma membrane and the organization of the immunological
synapse in human T cells (12, 13). The work reported in the
present study addresses the role of MAL in exosome secretion
in Jurkat T cells.
Materials and Methods
Reagents
The mAb 6D9 to human MAL has been described elsewhere (14). The sources of
the Abs to the indicated proteins used were as follows: CD59 from Abcam, CD63
from the Developmental Studies Hybridoma Bank (DSHB), tsg101 from Santa
Cruz Biotechnology, calnexin from Stressgen. Fluorescent Alexa–conjugated sec-
ondary Abs were obtained from Invitrogen. HRP-conjugated secondary Abs were
from Jackson ImmunoResearch Laboratories.
DNA constructs and transfection conditions
The DNA constructs expressing MAL-cherry and short hairpin (sh)RNA to MAL
have been described elsewhere (12, 13). The DNA construct expressing MAL
mRNA lacking 59 and 39 untranslated regions designed to be insensitive to
shMALa expression was made in the pCDNA3.1 Zeo vector (Invitrogen). The
DNA constructs expressing Nef-GFP and Rab5-Q79L-GFP (Addgene plasmid
35140) were gifts from A. Alcover (Institut Pasteur, Paris, France) and
S. Grinstein (Hospital for Sick Children, Toronto, ON, Canada). For stable
transfection, Jurkat cells were selected with the 1 mg/ml G418 or 1 mg/ml
Zeocin, cloned by limiting dilution. The resulting clones were screened by
immunoblotting with anti-MAL mAb 6D9.
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Isolation and analysis of exosomal fractions
To isolate the 100,000 3 g exosomal fraction of Jurkat cells by differential
centrifugation or by centrifugation to equilibrium we followed standard
protocols (15). Samples were subjected to SDS-PAGE and processed for
immunoblotting. Band intensities were quantified using ImageJ software, and
results were expressed relative to the control condition.
Quantification of the number of exosome particles
Aliquots of the resuspended 100,000 3 g exosomal pellet of control and MAL
knockdown (KD) cells were deposited on EM grids and processed for whole-
mounted analysis under an electron microscope following an established protocol
(15). Images taken from different fields were then systematically analyzed for the
presence of 40- to 100-nm vesicles.
Immunofluorescence analysis
Cells were fixed in formalin for 30min, rinsed, and treated with 10mM glycine
in PBS for 5 min. Immunofluorescence analysis was carried out as described
elsewhere (12). For time-lapse fluorescence microscopy, cells were plated onto
fibronectin-coated chambers and imaged using an AF6000 LX microscope
(Leica). Brightness and contrast were optimized with Adobe Photoshop CS6
software. Quantifications were performed using ImageJ software.
Correlative light-electron microscopy
Jurkat cells expressing CD63-GFP attached to gridded glass-bottom dishes were
fixed with 4% paraformaldehyde. Selected cells expressing CD63-GFP were
visualized by z-stack imaging (optical section, 300 nm) using a Zeiss L510 laser
confocal microscope. Phase contrast light microscopy was used to map the
position of the selected cells on the gridded coverslip. Cells were further fixed with
2% glutaraldehyde followed by 2% osmium tetroxide. After Epon embedding,
cells were ultrasectioned entirely along their z-axis into serial 80-nm-thick sec-
tions, which were poststained with uranyl acetate and lead citrate. Samples were
then examined at 80 kV in a Jeol JEM-1010 electron microscope. Selected
fluorescent images exhibiting multiple CD63+ spots were mapped onto the
corresponding electron microscopy sections by overlapping them manually with
the help of Adobe Photoshop CS6.
FIGURE 1. MAL is required for constitutive exosome secretion. (A) The exosomal 100,0003 g pellet fraction was centrifuged to equilibrium in a 2.0–0.25 M sucrose
density gradient. Aliquots from the different fractions were analyzed by immunoblotting with the indicated Abs. (B) Electron microscopy image of a whole-mount
exosomal sample from control cells stained with uranyl acetate. The inset shows the boxed region at higher magnification. Scale bars, 100 nm. (C) Total cell extracts (left)
and exosome fractions (right) from equal numbers of cells from control cells or cells stably silenced for MAL with shMALa were immunoblotted for the indicated proteins.
(D) Levels of CD63, CD59, and tsg101 represented as the percentage relative to control cells in the exosome fraction of wild-type cells silenced for MAL with shMALa cell
clones 1 and 2 or shMALb and in cells stably expressing exogenous MAL resistant to shMALa expression (shMALaMALRes). The broken line indicates 100% secretion of
each of the proteins analyzed in the control cells. (E) The numbers of 40- to 100-nm vesicles in electron microscopy images of whole-mount exosome samples from control
and MAL KD cells were quantified. Approximately 900 and 450 vesicles with these characteristics were identified in the samples from control cells and MAL KD cells,
respectively, upon analysis of the same number of images. (F) Cells coexpressing MAL-cherry and CD63-GFP were examined by time-lapse videomicroscopy. The
arrowhead indicates a vesicle positive for both MAL and CD63 that fuses with the plasma membrane and discharges its contents. Scale bar, 5 mm. An enlargement of the
boxed region is shown on the right for CD63-GFP. The contrast of the enlarged images was adjusted to show the fusion event and the material released into the ex-
tracellular space more clearly. Scale bar, 1 mm. Numbers indicate time in seconds. Means 6 SEM of three independent experiments are shown in (D) and (E).
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Statistical analysis
Data are expressed as the means6 SEM. A Student t test was used to calculate
the statistical significance of differences between group means.
Results and Discussion
To analyze exosome secretion by Jurkat cells, we chose CD63,
CD59, and tsg101 as being representative of tetraspanins, GPI-
anchored proteins, and the ESCRT machinery, respectively. To
characterize the exosomes, the fraction obtained by differential
centrifugation of the culture medium was centrifuged in a su-
crose density gradient. The three exosomal markers showed
clear enrichment in the 1.12 and 1.16 g/ml fractions (Fig. 1A).
The exosomes had the size and typical collapsed morphology
(Fig. 1B) reported for exosomes analyzed as whole-mount
samples (1). Therefore, according to their density, morphol-
ogy, and size, the vesicles isolated by differential centrifugation
are enriched in bona fide exosomes.
We generated cell clones stably silenced for MAL expression
using two shRNAs (shMALa and shMALb). These cell clones,
which immunoblotting assays revealed their endogenous MAL
levels to be reduced reduced by .98% (Supplemental Fig. 1A),
were then used to compare the release of the exosome markers. A
drop in exosome marker secretion was observed in cells knocked
down for MAL expression with shMALa, clones 1 and 2, and
small interfering MALb. However, this was not apparent in
shMALa KD cells expressing exogenous MAL that was resistant
to small interfering MALa (MALRes) (Fig. 1C, 1D). As a con-
trol we observed that the total cellular content of the markers was
not altered by the absence of MAL expression in shMALa clone
1 cells, which we subsequently refer to as MAL KD cells
(Supplemental Fig. 1B). Consistent with the reduced secretion of
the markers, it is of note that exosomes were secreted in small
amounts byMAL KD cells, taken as the number of 40- to 100-nm
vesicles secreted by equal numbers of cells, measured under an
electron microscope (Fig. 1E). The total protein content in
the exosome pellet of MAL KD cells, determined by the Brad-
ford assay, was ∼50% of that in control cells. Because the
100,000 3 g pellet almost certainly contains other types of
material (e.g., apoptotic bodies, shedding vesicles), this decrease
may well account for the block observed in the number of
exosomes in MAL KD cells (Fig. 1E).
We took CD63 to be representative of exosome cargo and
coexpressed CD63-GFP and MAL-cherry to analyze the dy-
namics of MAL and CD63 simultaneously by time-lapse
FIGURE 2. MAL silencing diverts CD63 to autophagic vacuoles and lysosomes. (A) MAL KD cells expressing CD63-GFP cells were examined by time-lapse video-
microscopy. Scale bars, 5 mm. An enlargement of the boxed region is shown. Scale bar, 1 mm. Numbers indicate time in seconds. (B) Control (top panels) and MAL KD
(bottom panels) cells transiently expressing CD63-GFP were fixed and processed for correlative light-electron microscopy analysis. The left panels show the confocal section and
the equivalent physical section. Scale bars, 5 mm. The boxed regions are shown at higher magnification. Scale bars, 500 nm. The arrows point to MVE and the arrowheads to
lysosomes and autophagic vacuoles. g, Golgi; n, nucleus. (C–E) Control or MAL KD cells transiently expressing Rab5-Q79L-GFP were stained for CD63. A confocal plane
is shown. Scale bars, 5 mm. An enlargement of the boxed areas is shown. Scale bars, 1 mm (C). The histograms represent the percentage of CD63 in the limiting membrane
relative to the total content in each individual Rab5-Q79L+ endosome analyzed (D), and the total content of CD63 in individual Rab5-Q79L endosomes in MAL KD cells
is expressed as the percentage relative to that in control cells (E). Three independent experiments were performed. Means 6 SEM are shown in (E).
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videomicroscopy. We detected endosome structures that were
positive for both proteins. Occasionally, we observed that these
endosomes moved toward the plasma membrane and dis-
charged their content into the extracellular space, leaving a halo
of secreted CD63+ exosomes (Fig. 1F, Supplemental Video 1).
In summary, MAL, which is present with exosomal cargo in
the same endosomes that travel to the plasma membrane for
exosome secretion, is required for the release of exosomes.
When we compared the dynamics of CD63 in MAL KD
cells (Fig. 2A, Supplemental Video 2) with that of control
cells (Fig. 1F, Supplemental Video 1), the most obvious effect
of MAL KD was the accumulation of CD63 in apparently
large intracellular structures that moved erratically and were
unable to fuse with the plasma membrane. These structures
were characterized by correlative light-electron microscopy as
being lysosomes and autophagic vacuoles (Fig. 2B). We used
Rab5-Q79L expression as a tool to generate large MVE,
which facilitate the analysis of the role of MAL in sorting
CD63 to ILV. It is of particular note that, consistent with the
impairment of the secretion of CD63 and with its presence in
autophagic vacuoles, CD63 showed ∼14% missorting to the
limiting membrane in MAL KD cells (Fig. 2C, 2D). Because
exosome secretion was inhibited in MAL KD cells, the mis-
sorted pool of CD63 might reflect the population of CD63+
ILV normally destined for secretion in exosomes, whereas the
luminal CD63 would correspond to the pool of ILV nor-
mally destined for fusion with lysosomes. As a control, we
observed that the levels of CD63 in enlarged Rab5-Q79L+
MVE were similar in control and MAL KD cells (Fig. 2E).
We conclude that MAL is necessary for the efficient fusion
of endosomes with the plasma membrane so that they can
discharge their ILV content into the extracellular space in
the form of exosomes, and for correctly sorting the exo-
somal cargo in MVE.
Expression of the HIV-1 accessory protein Nef in T cells
induces massive secretion of exosome markers (16, 17). We
examined whether Nef targets the MAL-dependent route.
The percentage of Nef-transfected cells and the levels of
Nef expression were similar in control and MAL KD cells
(Supplemental Fig. 2). Consistent with a previous report
(17), Nef induced secretion of all the exosome markers
analyzed. It is of note that Nef could not overcome the
block on exosome marker secretion imposed by MAL KD
(Fig. 3). These findings indicate that HIV-1 Nef induces
exosome marker secretion by exploiting the MAL-mediated
constitutive route of exosome biogenesis. Bearing in mind
that exosome particle secretion is inhibited in MAL KD
cells (Fig. 1E), it is reasonable to suppose that the drastic
reduction of exosome marker release observed in Nef-
transfected MAL KD cells is due to deficient exosome
biogenesis.
Exosome modulation has the therapeutic potential to fight
T cell–mediated diseases and HIV-1 infection (2–6). Our
results point to the integral MAL protein being a key element
of the protein machinery for exosome secretion and a candi-
date protein target for modulating exosome release in human
T cells.
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